How often is Risperdal Consta given?

Risperdal Consta, which is a long-acting injectable formulation of the antipsychotic medication risperidone, is typically administered every two weeks. This dosing schedule is designed to maintain therapeutic drug levels in the body while ensuring adherence to treatment, as the extended-release formulation provides steady plasma concentrations over a longer period.

Administering it biweekly helps to reduce the burden of daily medication routines, which can improve patient compliance and overall treatment success. This is particularly important for individuals with conditions like schizophrenia or bipolar disorder, where consistent medication adherence is crucial for effective management of symptoms.

While the other options suggest either more frequent or less frequent dosing, they do not align with the recommended administration schedule for Risperdal Consta, which is firmly established as every two weeks in clinical practice.